Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.54 |
| ▸ | HTT | P42858 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 2/20 | 0.53 |
| ▸ | TP53 | P04637 | 1/20 | 0.52 |
| ▸ | POLB | P06746 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | SIRT5 | Q9NXA8 | 1/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.50 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | NPC1 | O15118 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 1/20 | 0.50 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.48 |
| ▸ | PTBP1 | P26599 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4461408 | 0.83 | OPRM1 (0.49) | L3MBTL1ALDH1A1HTTLMNATP53 | |
| SCHEMBL8785311 | 0.83 | SLC7A5 (0.50) | L3MBTL1ALDH1A1HTTLMNATP53 | |
| SCHEMBL359468 | 0.81 | CYP1A2 (0.60) | L3MBTL1ALDH1A1HTTLMNATP53 | |
| SCHEMBL28179453 | 0.81 | ALDH1A1 (0.51) | L3MBTL1ALDH1A1HTTLMNATP53 | |
| SCHEMBL27718547 | 0.81 | L3MBTL1 (0.50) | L3MBTL1ALDH1A1HTTLMNATP53 | |
| SCHEMBL6973576 | 0.81 | L3MBTL1 (0.50) | L3MBTL1ALDH1A1HTTLMNATP53 | |
| SCHEMBL10921299 | 0.80 | ALDH1A1 (0.47) | L3MBTL1ALDH1A1HTTLMNATP53 | |
| SCHEMBL19824761 | 0.80 | LTA4H (0.49) | ALDH1A1HTTLMNATDP1MEN1 | |
| SCHEMBL28638612 | 0.80 | TSHR (0.59) | L3MBTL1ALDH1A1HTTLMNATP53 | |
| SCHEMBL13315847 | 0.79 | LTA4H (0.42) | L3MBTL1ALDH1A1HTTLMNATP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 257 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12239760-B1 | Antibacterial conductive self-healing hydrogel | Najran University (SA) | 2025-03-04 | — | — | US | claimed |
| CN-114525596-A | Antistatic high-strength polyacrylonitrile fiber and preparation method thereof | 吕建刚 | 2022-05-24 | — | — | CN | claimed |
| EP-1329160-A2 | 4-ACYLAMINOPYRAZOLE DERIVATIVES | Sankyo Company, Limited (JP) | 2003-07-23 | — | — | EP | claimed |
| US-20260131048-A1 | SELF-HEALING HYDROGEL WOUND DRESSING | Najran University (SA) | 2026-05-14 | — | — | US | disclosed |
| US-12239760-B1 | Antibacterial conductive self-healing hydrogel | Najran University (SA) | 2025-03-04 | — | — | US | disclosed |
| WO-2024182778-A1 | COMPOUNDS AND METHODS FOR MODULATING SPLICING | REMIX THERAPEUTICS INC. (US) | 2024-09-06 | — | — | WO | disclosed |
| EP-3664199-B1 | LITHIUM SECONDARY BATTERY POLYMER MATERIAL AND MANUFACTURING METHOD THEREFOR | LG ENERGY SOLUTION LTD (KR) | 2023-08-30 | — | — | EP | disclosed |
| CN-111033835-B | Lithium secondary battery polymer material and method for producing same | 株式会社LG新能源 | 2023-05-09 | — | — | CN | disclosed |
| US-11618748-B2 | Dual mechanism inhibitors for the treatment of disease | AERIE PHARMACEUTICALS, INC. (US) | 2023-04-04 | — | — | US | disclosed |
| CN-115433205-A | Polycyclic derivative receptor agonist, preparation method and application thereof | 上海翰森生物医药科技有限公司 | 2022-12-06 | — | — | CN | disclosed |
| US-20220267300-A1 | SULFONAMIDE DERIVATIVES AND USES THEREOF | NodThera Limited (GB) | 2022-08-25 | — | — | US | disclosed |
| US-RE30655-E | Process for preparing 3-thienyl-acetate derivatives | LABAZ (FR) | 1981-06-23 | — | — | US | disclosed |
| US-4262129-A | Preparation of a 3-thienylmalonic acid and the corresponding diesters | OCE-ANDENO B.V. (NL) | 1981-04-14 | — | — | US | disclosed |
| US-4252976-A | Process for the preparation of thiophenes | BEECHAM GROUP LIMITED (DE) | 1981-02-24 | — | — | US | disclosed |
| US-4186137-A | ALKYLATION WITH CYCLOHEXYL BROMIDE | LABAZ (FR) | 1980-01-29 | — | — | US | disclosed |
| EP-0002846-A1 | 3-Thienylmalonic acids, the corresponding diesters and their preparation | Océ-Andeno B.V. (NL) | 1979-07-11 | — | — | EP | disclosed |
| EP-0000633-A2 | Process for the preparation of alpha-substituted-thien-3-ylacetic acid and derivatives thereof | BEECHAM GROUP PLC (GB) | 1979-02-07 | — | — | EP | disclosed |
| US-4107178-A | Thioprene or furan derivatives and process for preparation thereof | SAGAMI CHEMICAL RESEARCH CENTER (JP) | 1978-08-15 | — | — | US | disclosed |
| US-4086420-A | Thioprene or furan derivatives and process for preparation thereof | SAGAMI CHEMICAL RESEARCH CENTER (JA) | 1978-04-25 | — | — | US | disclosed |
| US-4051151-A | Thiophene derivatives and process for preparation thereof | SAGAMI CHEMICAL RESEARCH CENTER (JA) | 1977-09-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11618748-B2 | Dual mechanism inhibitors for the treatment of disease | RHOA, SLC6A2, ROCK2 | L3MBTL1 4562/4885ALDH1A1 1686/4885HTT 526/4885 |
| US-20220267300-A1 | SULFONAMIDE DERIVATIVES AND USES THEREOF | IL1B, IL1A, CASP1 | L3MBTL1 4200/4885ALDH1A1 226/4885HTT 4669/4885 |
| US-20260131048-A1 | SELF-HEALING HYDROGEL WOUND DRESSING | CLTC, PPP3CB, CLTB | L3MBTL1 451/4885ALDH1A1 189/4885HTT 2174/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.